1.
Dong K, Wang G, Wang ZL, Wang X. Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma. Bangladesh J Pharmacol [Internet]. 2019 Feb. 7 [cited 2024 Nov. 24];14(1):32-5. Available from: https://banglajol.info/index.php/BJP/article/view/38807